Despite Trump's Tough Talk On PBMs, GOP House Lets Them Off The Hook

Contributing sentiments towards policy:

54% : The House of Representatives stripped language from legislation attached to a bill designed to fund the government that would increase regulation of PBMs which are considered middlemen between drug companies and consumers when it comes to purchasing medicines, administer drug benefits for employers and government health insurance including Medicaid coverage for poor Americans and Medicare benefits for seniors.
51% : "What's more, the pharmacy lobby said the legislation would have required the Centers for Medicare & Medicaid Services "to establish reasonable and relevant contract terms, including pharmacy reimbursements, in Medicare Part D and create a mechanism for pharmacies to dispute contract violations and penalize PBMs.
19% : "The horrible middleman that makes more money, frankly, than the drug companies, and they don't do anything except they're a middleman," USA Today reported Trump as saying Monday.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.